Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Regeneron Ventures

Corporate VC Connecticut, United States ·Founded 2024

Overview

Regeneron Ventures is a corporate venture capital fund established in April 2024, focusing on investing in early-stage biotechnology and health technology companies. Operating independently from its sole limited partner, Regeneron Pharmaceuticals, Inc., the fund shares a patient-centric, science-based mission, principles, and values. Its investment mandate encompasses healthcare broadly, with a particular emphasis on biotechnology, medical devices, tools, and enabling technologies. Investment decisions are based on the quality of the people, science, and data, favoring breakthrough innovations and tolerating risk and uncertainty. The fund aims to help portfolio companies transform great ideas into impactful products for patients, driving investment results through this mission. The general partner is independently managed by former Regeneron executives Jay S. Markowitz, M.D., and Michael Aberman, M.D., who lead the fund's investment strategy. Regeneron Pharmaceuticals, Inc. is the fund's exclusive limited partner, committing $100 million annually for five years.

Investment Focus

Focus on biotechnology, medical devices, tools, and enabling technologies
Preference for breakthrough innovations
Tolerance for risk and uncertainty
Alignment with patient-centric, science-based mission

Reach Regeneron Ventures directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Regeneron Ventures

What sectors does Regeneron Ventures invest in?

Regeneron Ventures invests in Pharmaceuticals, Medical Devices, Biotechnology and Health Technology, and is based in Connecticut, United States. Regeneron Ventures is listed as a corporate vc in the ConnectSafely investor database.